Surprisingly, ADAMTS13-Act was not related to VWF biomarkers or the VWF-Ag/-A ratio, and also similar between different stages of PH and liver dysfunction in our cohort of clinically stable ACLD patients and liver-healthy controls, which add important data to the controversy on ADAMTS13-Act in ACLD. Here, VWF is linked to Decreased liver function.